Close

Durata Therapeutics (DRTX): FDA Adcomm Panel Backs Dalbavancin

March 31, 2014 3:57 PM EDT Send to a Friend
(Updated - March 31, 2014 5:11 PM EDT)

Durata Therapeutics, Inc. (Nasdaq: DRTX) announced today that the U.S. Food ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login